- Previous Close
44.06 - Open
43.90 - Bid 43.24 x 3800
- Ask 43.22 x 82100
- Day's Range
42.74 - 43.92 - 52 Week Range
32.74 - 50.05 - Volume
17,969 - Avg. Volume
33,432 - Market Cap (intraday)
900.943M - Beta (5Y Monthly) 1.33
- PE Ratio (TTM)
24.98 - EPS (TTM)
1.73 - Earnings Date Mar 27, 2025
- Forward Dividend & Yield 0.05 (0.12%)
- Ex-Dividend Date Jun 27, 2024
- 1y Target Est
56.50
Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; ophthalmological products; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration related sources for radioisotopes. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.
www.ezag.comRecent News: EUZ.DE
View MorePerformance Overview: EUZ.DE
Trailing total returns as of 1/3/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EUZ.DE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EUZ.DE
View MoreValuation Measures
Market Cap
918.45M
Enterprise Value
872.74M
Trailing P/E
24.98
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.24
Price/Book (mrq)
3.63
Enterprise Value/Revenue
3.08
Enterprise Value/EBITDA
12.21
Financial Highlights
Profitability and Income Statement
Profit Margin
12.22%
Return on Assets (ttm)
7.69%
Return on Equity (ttm)
16.68%
Revenue (ttm)
273.51M
Net Income Avi to Common (ttm)
37.72M
Diluted EPS (ttm)
1.73
Balance Sheet and Cash Flow
Total Cash (mrq)
76.62M
Total Debt/Equity (mrq)
21.96%
Levered Free Cash Flow (ttm)
-41.02M